- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Thoracic Surgery, Lung Isolation in Canada
Total 900 results
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung CancerCanada, Netherlands, Spain, France, Japan, Russian Federation, Germany, Belgium, Greece, Turkey, Taiwan, United States
-
Geron CorporationCompletedNon-small Cell Lung CancerUnited States, Canada, Germany
-
Bristol-Myers SquibbTerminatedNon-small Cell Lung CancerSpain, Belgium, France, Italy, Netherlands, Canada, United Kingdom, United States
-
Daiichi SankyoAstraZenecaActive, not recruitingNon-Small Cell Lung CancerUnited States, Spain, Korea, Republic of, Italy, France, Japan, Taiwan, Netherlands, Australia, Canada
-
GlaxoSmithKlineTerminatedLung Cancer, Non-Small CellUnited States, Canada
-
Astellas Pharma IncCompletedNSCLC | Non Small Cell Lung CancerUnited States, Canada, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Fundación GECPRecruitingLung Diseases | Carcinoma, Non-Small-Cell Lung | Respiratory Tract Neoplasms | Thoracic Neoplasms | Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Carcinoma Bronchiogenic Stage IIISpain
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerFrance, Spain, United States, Canada, Korea, Republic of, Austria, Israel, Germany
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerSpain
-
AmgenCompletedNon Small Cell Lung CancerUnited States, Canada, Australia, Spain, Belgium, Greece
-
AstraZenecaActive, not recruitingAdvanced Non Small Cell Lung CancerCanada, Poland, Taiwan, United States, Korea, Republic of, Japan, Russian Federation, Ukraine
-
Bristol-Myers SquibbCompletedLung CancerItaly, United States, France, Russian Federation, Spain, Argentina, Belgium, Brazil, Canada, Chile, Czechia, Germany, Greece, Hungary, Mexico, Netherlands, Poland, Romania, Switzerland, Turkey, United Kingdom
-
PfizerTerminatedNon-small Cell Lung Cancer | Urothelial CancerSpain, Czechia, United States, Australia, United Kingdom, Italy, Canada, Hungary
-
CTI BioPharmaTerminatedNSCLCUnited States, Canada, Bulgaria, Romania, Russian Federation, Ukraine, Mexico, Argentina, Hungary, Poland, United Kingdom
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedLung CancerUnited States, Canada
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedLung CancerUnited States, Hungary, Spain, Ireland, Italy, Taiwan, Korea, Republic of, United Kingdom, Turkey, Canada, Israel, Australia, Mexico, Russian Federation
-
ImmunoGen, Inc.TerminatedSmall Cell Lung CancerUnited States, Spain, Canada, United Kingdom
-
University of WashingtonNational Heart, Lung, and Blood Institute (NHLBI); American Thoracic Society; American Society for Parenteral and Enteral Nutrition and other collaboratorsCompletedAcute Respiratory Distress Syndrome | Acute Lung Injury | Respiratory Distress Syndrome, AdultUnited States, Canada
-
Hoffmann-La RocheCompletedCarcinoma, Non-Small-Cell LungItaly, Netherlands, Argentina, Brazil, China, Denmark, Greece, Panama, Spain, United Arab Emirates, United Kingdom, Mexico, Poland, Peru, Philippines, Costa Rica, Malaysia, Morocco, Latvia, Lebanon, Sweden, Slovenia, Colombia, Guatemala
-
NovaceaUnknownNon Small Cell Lung Cancer (NSCLC) | Androgen Independent Prostate Cancer (AIPC)Canada, United States
-
ILEX Oncology Services, IncorporatedCompletedLung CancerUnited States, Canada
-
Genentech, Inc.RecruitingColorectal Cancer | Non-Small Cell Lung CancerKorea, Republic of, Australia, Canada, United States
-
GlaxoSmithKlineCompletedLung CancerUnited States, Canada, Puerto Rico
-
Regeneron PharmaceuticalsSanofiTerminatedNon-small Cell Lung Cancer | Advanced CarcinomaUnited States, Canada
-
AstraZenecaCompletedSmall Cell Lung Carcinoma Extensive DiseaseSpain
-
GlaxoSmithKlineMerck Sharp & Dohme LLCTerminatedNeoplasmsUnited States, Spain, Netherlands, United Kingdom, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Terminated
-
SanofiCompletedSquamous Cell Lung CancerCanada, Belgium, Spain, United States, France, Germany, Hungary, Israel, Italy, Luxembourg, Netherlands, Poland, Romania, United Kingdom
-
Spanish Lung Cancer GroupTerminatedNon Small Cell Lung Cancer | BRCA1 MutationSpain
-
AstraZenecaCompletedNon Small Cell Lung CancerItaly, United States, Canada, Korea, Republic of, Japan, Taiwan, Hong Kong, Spain
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States, Canada
-
ETOP IBCSG Partners FoundationRoche Pharma AGActive, not recruitingEGFRmutant Stage IIIB/C or IV Non-squamous NSCLCSingapore, Spain, Korea, Republic of, Switzerland, Germany
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedLung CancerUnited States, Canada
-
University of ColognePfizer; Spanish Lung Cancer GroupCompletedAdenocarcinoma | NSCLC | Lung CancerGermany, Spain, Switzerland
-
Seagen Inc.RecruitingCarcinoma, Non-Small-Cell LungUnited States, Canada, Belgium, Spain, Poland, Germany, Italy, Greece, Norway, Hungary, France, Czechia, Netherlands, Romania
-
TakedaCompletedNon-small Cell Lung Cancer (NSCLC)Hong Kong, France, Canada
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaActive, not recruitingBreast Cancer | Colorectal Cancer | Non-small Cell Lung Cancer | Genitourinary Cancer | Rare Cancers | Gynecological Cancers | Pancreatobiliary Gastrointestinal Cancer | Upper Aerodigestive Tract Cancer | Melanoma Cancers | Unknown Primary CancersCanada
-
PfizerCompleted
-
AnHeart Therapeutics Inc.RecruitingNon Small Cell Lung CancerUnited States, Spain, France, Italy, Japan, Korea, Republic of, Canada, China, Poland
-
Integrated DiagnosticsCompleted
-
CTI BioPharmaTerminated
-
BayerCompletedCarcinoma, Non-Small-Cell LungItaly, Spain, Canada, United States, Germany, Israel
-
CelgeneBeiGeneTerminatedCarcinoma, Non-Small-Cell LungSpain, United States, Japan, China, Canada, United Kingdom, Belgium, Singapore, Korea, Republic of, Netherlands, France, Romania, Greece, Germany, Taiwan, Finland, Italy, Poland, Hungary, Ireland, Portugal, New Zealand, Russian Federation
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung Cancer (NSCLC)Japan, Germany, Spain, Italy, France, Thailand, Belgium, Netherlands, India, Malaysia, Taiwan, Australia, Canada, Czechia, Greece, Hong Kong
-
Fundación GECPCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheRecruitingNon-Small Cell Lung CancerKorea, Republic of, United States, Australia, Brazil, China, United Kingdom, Israel, Belgium, Netherlands, Argentina, Spain, Taiwan, Canada, Italy, Poland, Turkey, Sweden, Switzerland
-
AstraZenecaRecruitingNon-small Cell Lung CancerSpain, Italy, France, Canada, Portugal, United States, Czechia, Germany, Sweden, Austria, Hungary
-
Millennium Pharmaceuticals, Inc.CompletedSmall Cell Lung CancerUnited States, France, Germany, Spain, Belgium, Poland, Canada, Hungary, Italy, Czechia